Document Detail


Eptifibatide-Induced Thrombocytopenia-When Inhibitor Turns Killer.
MedLine Citation:
PMID:  24368608     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Eptifibatide is a commonly and widely used drug for management of acute coronary syndrome and during percutaneous coronary intervention. It is usually well tolerated with no major adverse effects. We report a rare case of life-threatening thrombocytopenia secondary to eptifibatide along with a literature review of available evidence.
Authors:
Naga Venkata Pothineni; Thomas E Watts; Zufeng Ding; Yao Dai; Abhishek J Deshmukh
Related Documents :
24325998 - Pituitary apoplexy secondary to thrombocytopenia due to dengue hemorrhagic fever: a cas...
23198218 - Spontaneous rupture of the patellar tendon and the contralateral quadriceps tendon, ass...
23186978 - Cola-induced hypokalemia-a case report and review of the literature.
21343828 - Intent to update systematic reviews: results of an internet survey.
3772418 - Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement ...
914438 - The psychotic character.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-23
Journal Detail:
Title:  American journal of therapeutics     Volume:  -     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Health Related Quality of Life and Social Support in Pediatric Patients with Pacemakers.
Next Document:  Prevention of Hepatitis B Virus Reactivation With Lamivudine in a Patient With Advanced Renal Cell C...